Key Laboratory for Zoonosis Research, Ministry of Education, Institute of Zoonosis, Jilin University, Changchun, China.
Acta Pharmacol Sin. 2013 Feb;34(2):231-8. doi: 10.1038/aps.2012.155. Epub 2012 Dec 31.
To investigate the effects of the potassium-sparing diuretic amiloride on endothelial cell apoptosis during lipopolysaccharide (LPS)-accelerated atherosclerosis.
Human umbilical vein endothelial cells (HUVECs) were exposed to LPS (100 ng/mL) in the presence of drugs tested. The activity of Na(+)/H(+) exchanger 1 (NHE1) and calpain, intracellular free Ca(2+)level (Ca(2+)), as well as the expression of apoptosis-related proteins in the cells were measured. For in vivo study, ApoE-deficient (ApoE(-/-)) mice were fed high-fat diets with 0.5% (w/w) amiloride for 4 weeks and LPS (10 μg/mouse) infusion into caudal veins. Afterwards, atherosclerotic lesions, NHE1 activity and Bcl-2 expression in the aortic tissues were evaluated.
LPS treatment increased NHE1 activity and Ca(2+) in HUVECs in a time-dependent manner, which was associated with increased activity of the Ca(2+)-dependent protease calpain. Amiloride (1-10 μmol/L) significantly suppressed LPS-induced increases in NHE1 activity, Ca(2+). and calpain activity. In the presence of the Ca(2+) chelator BAPTA (0.5 mmol/L), LPS-induced increase of calpain activity was also abolished. In LPS-treated HUVECs, the expression of Bcl-2 protein was significantly decreased without altering its mRNA level. In the presence of amiloride (10 μmol/L) or the calpain inhibitor ZLLal (50 μmol/L), the down-regulation of Bcl-2 protein by LPS was blocked. LPS treatment did not alter the expression of Bax and Bak proteins in HUVECs. In the presence of amiloride, BAPTA or ZLLal, LPS-induced HUVEC apoptosis was significantly attenuated. In ApoE(-/-) mice, administration of amiloride significantly suppressed LPS-accelerated atherosclerosis and LPS-induced increase of NHE1 activity, and reversed LPS-induced down-regulation of Bcl-2 expression.
LPS stimulates NHE1 activity, increases Ca(2+), and activates calpain, which leads to endothelial cell apoptosis related to decreased Bcl-2 expression. Amiloride inhibits NHE1 activity, thus attenuates LPS-accelerated atherosclerosis in mice.
研究保钾利尿剂氨氯吡咪对脂多糖(LPS)加速动脉粥样硬化过程中内皮细胞凋亡的影响。
将人脐静脉内皮细胞(HUVECs)暴露于 LPS(100ng/ml),并加入测试药物。测量钠氢交换蛋白 1(NHE1)和钙蛋白酶的活性、细胞内游离钙浓度([Ca2+]i)以及细胞中凋亡相关蛋白的表达。在体内研究中,用含 0.5%(w/w)氨氯吡咪的高脂肪饮食喂养载脂蛋白 E 基因缺失(ApoE-/-)小鼠 4 周,并经尾静脉输注 LPS(10μg/只)。之后,评估主动脉组织中的动脉粥样硬化病变、NHE1 活性和 Bcl-2 表达。
LPS 处理以时间依赖性方式增加 HUVECs 中的 NHE1 活性和[Ca2+]i,这与钙依赖性蛋白酶钙蛋白酶活性的增加有关。氨氯吡咪(1-10μmol/L)显著抑制 LPS 诱导的 NHE1 活性、[Ca2+]i 和钙蛋白酶活性的增加。在钙螯合剂 BAPTA(0.5mmol/L)存在的情况下,LPS 诱导的钙蛋白酶活性增加也被消除。在 LPS 处理的 HUVECs 中,Bcl-2 蛋白的表达显著下降,而其 mRNA 水平没有改变。在氨氯吡咪(10μmol/L)或钙蛋白酶抑制剂 ZLLal(50μmol/L)存在的情况下,LPS 下调 Bcl-2 蛋白的作用被阻断。LPS 处理不改变 HUVECs 中 Bax 和 Bak 蛋白的表达。在氨氯吡咪、BAPTA 或 ZLLal 存在的情况下,LPS 诱导的 HUVEC 凋亡明显减弱。在 ApoE-/-小鼠中,氨氯吡咪的给药显著抑制 LPS 加速的动脉粥样硬化和 LPS 诱导的 NHE1 活性增加,并逆转 LPS 诱导的 Bcl-2 表达下调。
LPS 刺激 NHE1 活性,增加[Ca2+]i,激活钙蛋白酶,导致与 Bcl-2 表达下降相关的内皮细胞凋亡。氨氯吡咪抑制 NHE1 活性,从而减轻 LPS 加速的小鼠动脉粥样硬化。